Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Chinese Patent Office
Cerilliant
Baxter
Colorcon
Deloitte
Accenture
McKesson
AstraZeneca

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020489

« Back to Dashboard

NDA 020489 describes ANDRODERM, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the ANDRODERM profile page.

The generic ingredient in ANDRODERM is testosterone. There are sixty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 020489
Tradename:ANDRODERM
Applicant:Allergan Sales Llc
Ingredient:testosterone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 020489
Ingredient-typeAndrostanes
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 020489
Suppliers and Packaging for NDA: 020489
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489 NDA Allergan, Inc. 0023-5990 N 0023-5990-60
ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489 NDA Allergan, Inc. 0023-5992 N 0023-5992-30

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength2.5MG/24HR
Approval Date:Sep 29, 1995TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength5MG/24HR
Approval Date:May 2, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength2MG/24HR
Approval Date:Oct 20, 2011TE:RLD:Yes

Expired US Patents for NDA 020489

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-001 Sep 29, 1995 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-001 Sep 29, 1995 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-001 Sep 29, 1995 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-001 Sep 29, 1995 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-001 Sep 29, 1995 ➤ Sign Up ➤ Sign Up
Allergan Sales Llc ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Chubb
Johnson and Johnson
Chinese Patent Office
Queensland Health
Deloitte
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot